Benzinga's Top Downgrades

Analysts at Piper Jaffray downgraded Mirati Therapeutics, Inc. MRTX from Overweight to Neutral. The target price for Mirati Therapeutics has been lowered from $50 to $45. Mirati Therapeutics shares closed at $44.34 on Wednesday. Analysts at Macquarie downgraded Starz STRZA from undefined to Neutral. Starz shares closed at $40.44 on Wednesday. Analysts at UBS downgraded Natural Resource Partners LP NRP from Neutral to Sell. The target price for Natural Resources is set to $2.50. Natural Resources shares closed at $2.97 on Wednesday. BB&T Capital downgraded Accuride Corporation ACW to Hold. Accuride shares closed at $3.29 on Wednesday.